A thorough analysis of 1100 participants in the Parkinson’s Progression Markers Initiative (PPMI) recently revealed the high accuracy of CSF-derived α-synuclein SAA in diagnosing PD and identifying prodromal patients with a sensitivity of 93% and 86%, respectively [96]. Here, SNCA is linked to Parkinson disease.